Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Teva Pharmaceutical Industries has appointed John Nason, Teva’s Senior Vice President of European Technical Operations, as President, Teva Active Pharmaceutical Ingredients (TAPI), a role in which he will lead the company’s vertically integrated...

Lannett, a Philadelphia-headquartered generic drug manufacturer, has stopped expansion plans for its active pharmaceutical ingredient (API) manufacturing plant in Cody, Wyoming. Lannett says the decision to stop expansion on the API plant owned by...

Otsuka America Pharmaceutical, which received US Food and Drug Administration (FDA) approval for a so-called “smart pill” in 2017, has formed a partnership to support the marketing in the US of the drug–device combination product of Abilify...

The US Food and Drug Administration (FDA) has provided an update on its investigation into an impurity found in certain samples of valsartan, which is used to treat high blood pressure and heart failure. The investigation began in June 2018 after a...

WuXi AppTec, a Shanghai, China-headquartered contract service provider, has appointed Edward Hu, the company’s Chief Financial Officer (CFO), as Co-Chief Executive Officer (CEO) of the company. Hu will continue to report to Dr. Ge Li, Chairman and...

The European Commission (EC) has approved Novartis’ Kymriah (tisagenlecleucel), a chimeric antigen receptor (CAR) T-cell therapy, for two indications in leukemia and lymphoma. Kymriah was the first CAR-T cell therapy approved by the US Food and...

Roche's Genentech is planning staff reductions of more than 200 at its biomanufacturing facility in San Mateo, California. The company reported the changes in an August 10, 2018 WARN (Worker Adjustment and Retraining Notification Act) filing with...